InsiderTrades

Form 4 for SNPS Synopsys

Accepted 2025-12-22 00:00:00 ET · period of report 2025-12-19 · accession 0001865504-25-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-12-22 2025-12-19 SNPS Glaser Shelagh CFO M - OptEx $349.96 +3,657 20.5K +22% +$1.28M
DM 2025-12-22 2025-12-19 SNPS Glaser Shelagh CFO S - Sale+OE $460.77 -3,657 17.8K -17% -$1.69M
DM 2025-12-22 2025-12-19 SNPS Glaser Shelagh CFO M - OptEx $0.00 -3,657 5,365 -41% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-19 M A 1,044 $354.45 18,886 D — —
2 Common Common Stock 2025-12-19 S D 2,613 $460.77 17,842 D — —
3 Common Common Stock 2025-12-19 M A 2,613 $348.17 20,455 D — —
4 Common Common Stock 2025-12-19 S D 1,044 $460.77 17,842 D — —
5 Derivative Non-Qualified Stock Option (right to buy) 2025-12-19 M D 2,613 $0.00 10,448 D $348.17 · 2023-12-02 to 2029-12-02 2,613 Common Stock (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
6 Derivative Non-Qualified Stock Option (right to buy) 2025-12-19 M D 1,044 $0.00 5,365 D $354.45 · 2024-02-17 to 2030-02-17 1,044 Common Stock (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.